Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
69.1M
-
Shares change
-
-16.5M
-
Total reported value, excl. options
-
$50M
-
Value change
-
-$12.2M
-
Put/Call ratio
-
3.9
-
Number of buys
-
42
-
Number of sells
-
-51
-
Price
-
$0.72
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2024
119 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2024.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.1M shares
of 170M outstanding shares and own 40.57% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (22.7M shares), VANGUARD GROUP INC (6.29M shares), TANG CAPITAL MANAGEMENT LLC (2.41M shares), MILLENNIUM MANAGEMENT LLC (1.78M shares), BlackRock Inc. (1.76M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.43M shares), GEODE CAPITAL MANAGEMENT, LLC (1.13M shares), Hudson Bay Capital Management LP (1M shares), and NORTHERN TRUST CORP (722K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.